Exhaled nitric oxide in paediatric asthma.
Assessment of airway function is difficult in young children with asthma, and in addition, only reflects the status of the disease at the time of the measurement. Thus, there is increasing interest in monitoring airway inflammation in asthma, which may provide a longer term assessment of disease activity. Most methods of assessing asthmatic inflammation are invasive, and are not feasible in the paediatric population. This review discusses exhaled nitric oxide as a marker of asthmatic inflammation, and compares it with other recognized markers. Exhaled nitric oxide has the potential to become a noninvasive method of assessing asthma control in the paediatric population.
Ratnawati
R
R
Faculte of Medicine, UNSW, Australia.
Thomas
P S
PS
D001249:Asthma / Q000378:metabolism*; D015415:Biomarkers / Q000032:analysis; D001944:Breath Tests; D002648:Child; D006801:Humans; D009569:Nitric Oxide / Q000032:analysis*; D012720:Severity of Illness Index
D015415:Biomarkers; D009569:Nitric Oxide